Nanofitin-Engineered Affinity Chromatography for Marker-Defined Extracellular Vesicle Enrichment in Scalable Downstream Processing

Abstract

Extracellular vesicles (EVs) are lipid bilayer-enclosed particles that mediate intercellular communication through the transfer of bioactive molecules. Their growing relevance in translational applications demands downstream purification workflows that are selective, scalable, and compatible with robust impurity control. Conventional EV isolation methods primarily rely on physicochemical properties such as size, density, or charge and therefore co-enrich overlapping EV fractions together with non-vesicular impurities. Here, we establish a Nanofitin(R)-based affinity chromatography workflow for selective enrichment of a CD81-positive EV fraction under EV-compatible elution conditions. Nanofitin(R) candidate NF06 was identified by ribosome display against the large extracellular loop of CD81 and combined nanomolar affinity with favorable release behavior while retaining binding after repeated regeneration cycles. Static screening with recombinant CD81 and HEK293-derived EVs identified 1 M arginine at pH 10 as the most suitable elution condition. Dynamic chromatography on a 1 mL column using tangential flow filtration-concentrated HEK293 conditioned medium achieved 66.9% overall recovery with an elution step yield of 57.7%. In parallel, dsDNA, host cell protein, and total protein were reduced by 2 to 3 log relative to conditioned medium. Nano flow cytometry showed enrichment of the CD81-positive EV fraction from 40% in conditioned medium to more than 90% in the eluates, together with a smaller and narrower particle size distribution. These results demonstrate that Nanofitin(R)-based affinity chromatography provides a practical route toward marker-defined EV enrichment that combines selective capture, EV-compatible release, and substantial impurity clearance in a chromatography-compatible process format.